Leading Health and Life Sciences in Nova Scotia

BioFuture 2030

We’ve launched BioFuture 2030
An Economic Growth Plan for Nova Scotia’s Health and Life Sciences Sector

International BioPartnering Program

Learn more about the International BioPartnering Program

Latest News

Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26m in Gross Proceeds

Read Orginal Article Here December 16, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) ...
Read More

NEWS

Motryx announces partnership with Aerocom

Read Original Article  Simple and reliable validation of Pneumatic Tube Systems for blood sample integrity monitoring Halifax, Canada, December 2020 – Motryx, provider of blood transport validation and verification services, today announced a partnership with Aerocom,...

DeCell Technologies Obtain First Ever in the World Patent Protection

DeCell Technologies has now obtained patents for its novel and innovative prECM™ decellularization technology in the U.S., Canada, and five countries in the E.U. (UK, France, Spain, Germany and Italy). These patents include process protection and for the first time...

Start-Ups Selected for Innovacorp’s Fall 2020 Sprint Program

Read Orginal Article Here Innovacorp received 60 submissions for its latest round of Sprint and, after many hours of reviewing and deliberating, selected nine companies to participate in the program. Congratulations to the start-ups chosen for Innovacorp’s 2020 Sprint...

EVENTS

No event found!

SOCIAL


Windsor NS & Charlottetown PEI based @BioVectra have safely onboarded over 150 new highly-skilled team members since the onset of the COVID-19 pandemic in 2020 👏. Check out the latest additions to their leadership team. https://t.co/zBfPOu7SyH

🎉Congrats to our members Precision BioLogic Inc., leading developers of #hemostasis diagnostic products, on the launch of their new #Lupus Anticoagulant Test in the U.S.

➡️Learn more:
https://t.co/ESX1ckuEd2 https://t.co/jwg2FjikF7
BioNovaNS photo

ABOUT BIONOVA

Our mandate is to:

  • LEAD the development of Health and Life Science in Nova Scotia
  • ACCELERATE companies and the business ecosystem
  • ADVOCATE for the sector and growth of Nova Scotia’s BioEconomy

OUR SECTOR STRENGTHS

  • Medical Technologies
  • Digital Health
  • Pharmaceuticals & Vaccines
  • Natural Health Products
  • BioProducts

Please visit our Sector Strengths page to learn more.

OUR ACCELERATION INITIATIVES

BioNova aims to accelerate the innovation and productivity of businesses in Nova Scotia’s bioeconomy through our Projects, Programs, Services & Events with the support of our stakeholders and funding partners.